There were 11 hypersensitivity reactions, all in patients receiving nivolumab. Reducing the infusion time for nivolumab and pembrolizumab to 10 minutes is feasible and safe, according to researchers.

Basel, 14 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced European Medicines Agency (EMA) approval of a new, shorter 90-minute Gazyvaro® (obinutuzumab) infusion time, administered in ...

Doctors prescribe Briumvi (ublituximab-xiiy) for certain forms of multiple sclerosis (MS). You’ll receive infusions (into your vein) over a period of months. Before each infusion, you’ll receive other ...

I speak with infusion leaders every day—from major health systems to independent infusion practices—and the same challenge comes up time and again: speed and efficiency with the intake and prior ...